|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 3.120 USD | +5.05% |
|
+6.48% | -13.57% |
| 08-12 | Altimmune, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-12 | Altimmune, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +5.05% | +6.48% | +8.71% | +13.87% | -13.57% | -13.81% | +17.74% | -73.06% | - | 607M | |
| -1.90% | +3.12% | +39.11% | +61.12% | +80.94% | +81.70% | +110.88% | +25.43% | - | 72.21B | |
| +0.87% | +15.32% | +16.70% | +28.12% | +22.43% | +56.99% | +95.59% | +228.57% | +6,400.74% | 63.98B | |
| +1.71% | -1.22% | +20.62% | +21.65% | -24.93% | +2.71% | +501.29% | +481.75% | +928.01% | 28.53B | |
| +4.18% | +9.36% | +30.68% | +50.88% | +59.03% | +63.29% | +25.63% | -52.52% | - | 25.07B | |
| +21.96% | +21.98% | +23.66% | +28.85% | +18.82% | +1.54% | +2.50% | -65.91% | - | 28.42B | |
| +2.28% | +5.65% | +15.14% | +29.87% | +6.17% | +42.00% | -12.34% | -27.52% | +94.05% | 20.04B | |
| 0.00% | -2.78% | +17.15% | +95.10% | +230.42% | +247.46% | +423.83% | +1,773.26% | +857.44% | 18.19B | |
| +2.96% | +2.66% | +7.04% | +23.46% | +37.56% | +25.17% | +534.71% | - | - | 15.96B | |
| +2.39% | +7.96% | -2.74% | +11.75% | +24.09% | +44.96% | +157.77% | +205.73% | +394.45% | 13.48B | |
| +1.72% | +2.48% | +20.34% | +22.18% | +34.67% | +350.20% | +216.38% | +53.15% | +1,092.13% | 12.63B | |
| +3.01% | +0.74% | -2.41% | +5.54% | -7.24% | +42.32% | +200.52% | +585.66% | +5,726.97% | 12.48B | |
| +6.49% | -8.25% | +1.82% | -17.35% | -15.88% | -41.54% | +198.90% | +163.66% | - | 10.49B | |
| +2.16% | +2.78% | -3.04% | +1.69% | +22.35% | +105.44% | +139.64% | +159.13% | +560.49% | 10.81B | |
| +2.26% | -13.18% | -5.07% | -17.29% | -25.04% | -48.28% | +644.89% | +83.10% | +92.23% | 10.46B | |
| +1.02% | +4.64% | +8.67% | +63.49% | +232.48% | +576.10% | +789.14% | -37.85% | -15.57% | 9.6B | |
| +4.17% | -1.58% | -3.04% | -5.36% | +12.78% | +3.51% | +130.35% | -14.53% | - | 8.81B | |
| -0.04% | +0.27% | +0.99% | +142.39% | +81.93% | +187.77% | +424.72% | +297.61% | - | 8.98B | |
| +5.87% | +6.12% | +12.63% | +29.77% | +37.19% | +99.50% | +27.06% | +212.44% | - | 9.42B | |
| +5.31% | +5.04% | +5.86% | +4.77% | +310.61% | +256.58% | +349.17% | -11.34% | - | 8.62B | |
| Average | +3.34% | +2.45% | +10.64% | +29.72% | +56.24% | +104.18% | +248.92% | +209.83% | +1,613.10% | 19.44B | |
| Weighted average by Cap. | +2.86% | +4.68% | +18.04% | +35.91% | +51.66% | +85.25% | +202.31% | +208.75% | +2,751.92% |
- Stock Market
- Stocks
- ALT Stock
- Sector Altimmune, Inc.
Select your edition
All financial news and data tailored to specific country editions
